Public policy decisions can directly influence how health innovations are funded, regulated, reimbursed, adopted, and accessed by patients. This AZBioPEERS video features a discussion hosted by Joan Koerber-Walker, AZBio CEO, with Steve Potts, CEO of Breakthru Medicine, and Tom Eisiminger, Jr., President and CEO of Regenesis Medical, on why policy engagement matters for health innovation entrepreneurs. Panelists will share perspectives on how founders and CEOs can stay informed, build relationships, and make their voices heard on issues that affect company growth, patient access, and Arizona’s broader life science ecosystemContinue reading
Author Archive: AZBio
Your Feedback Wanted on Proposed Changes to Reporting Peer Review Outcomes for Applications
NIH is seeking public comment on proposed changes to the reporting of peer review outcomes for grant applications (NOT-OD-26-088). Comments will be accepted electronically here until October 13, 2026.
These proposed updates are intended to strengthen alignment with the NIH Unified Funding Strategy which prioritizes scientific merit and reinforces the central role of peer review in NIH funding decisions. Under this framework, NIH Institutes, Centers, and Offices (ICOs) should consider peer review information in its entirety.Continue reading
HHS Seeks Public Input on Federal Vaccine Recommendation Categories and Shared Clinical Decision-Making
WASHINGTON, D.C. — AUGUST 21, 2026 — The U.S. Department of Health and Human Services (HHS) today announced a Request for Information (RFI) seeking public input on the categories used in federal vaccine recommendations and the role of shared clinical decision-making. The RFI advances President Trump’s Executive Order Delivering Gold Standard Childhood Vaccine Recommendations for Americans and supports the Task Force on Safer Childhood Vaccines.Continue reading
California SB 122: What It Means for Companies
California recently enacted SB 122, which represents a significant expansion of the state’s sales and use tax framework as it applies to digital products, including prewritten computer software delivered electronically and software accessed remotely, including most SaaS and cloud-based arrangements. Under the existing California sales and use tax framework, sales and use tax has generally applied to transactions involving tangible personal property. Persons engaged in the business of rendering services have historically been treated as consumers, not sellers, of tangible personal property used incidentally in rendering those services, and sales and use tax applied to the purchase of such tangible property by such service providers. Because California did not historically include electronically delivered software or SaaS in the definition of digital goods, effective January 1, 2027, the enactment of SB 122 marks a significant development for any company that sells into or buys from California, with meaningful downstream effects across sectors.Continue reading
University of Arizona and Gila River Health Care Launch Nation’s First MD-Granting Medical School Branch within a Tribal Nation
On August 18, 2028, the University of Arizona and Gila River Health Care (GRHC), the Gila River Indian Community’s tribally operated healthcare system, announced a long-term partnership to establish the nation’s first MD-granting medical school branch located on the lands of a sovereign Tribal Nation.Continue reading
Accelerating Angels Invests in Anuncia Medical
Investment supports a women-led, commercial-stage medical technology company improving outcomes for patients with hydrocephalus.
Continue reading
Eleven Aspirational Undergrads Intern with the College to Conduct Hypothesis-Driven Research
Now in its fourth year, the Flinn Foundation Summer Internship Program at the U of A College of Medicine – Phoenix continues to cultivate an environment of learning and innovation to inspire college-level students with a passion for science and medicine.
Medical Students and Residents Led Advocacy Event at the Arizona Capitol
A core aspect of professionalism for physicians is advocating for patients and a healthy community.Continue reading
Inspiration Found During Sabbatical Leads to Publication
Dr. Amelia Gallitano sought out a collaboration in Japan that would explore an unanswered research questionContinue reading
FDA Takes The Next Step In The PDUFA VIII Process
The Prescription Drug User Fee Act (PDUFA VIII) represents the eighth iteration of the foundational U.S. regulatory framework, governing FDA user fee funding and drug review performance commitments for Fiscal Years 2028 through 2032. Continue reading